Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1 ФГАОУ ВО «Российский университет дружбы народов им. Патриса Лумумбы», Москва, Россия; 2 Научно-исследовательский институт морфологии человека им. акад. А.П. Авцына ФГБНУ «Российский научный центр хирургии им. акад. Б.В. Петровского», Москва, Россия 3 ГБУЗ «Городская клиническая больница №36 им. Ф.И. Иноземцева» Департамента здравоохранения г. Москвы, Москва, Россия; 4 ФГБОУ ДПО «Российская медицинская академия непрерывного профессионального образования» Минздрава России, Москва, Россия omekan@mail.ru
Список исп. литературыСкрыть список 1. Centers for Disease Control and Prevention. The main statistics of the National Family Growth Survey are listing I. Retrieved 28 April 2020. https://www.cdc.gov/nchs/nsfg/key_statistics/i_2015-2017.htm#infertility 2. World Health Organization Infertility. https://www.who.int/news-room/fact-sheets/detail/infertility (accessed 11.07.2022) 3. Эседова А.Э., Меджидова А.М. Аденомиоз и бесплодие. Подходы к лечению. РМЖ. Мать и дитя. 2021; 2. https://cyberleninka.ru/article/n/adenomioz-i-besplodie-podhody-k-lecheniyu (дата обращения: 30.01.2023). [Esedova A.E., Medzhidova A.M. Adenomioz i besplodie. Podkhody k lecheniiu. RMZh. Mat' i ditia. 2021; 2. https://cyberleninka.ru/article/n/adenomioz-i-besplodie-podhody-k-lecheniyu (data obrashcheniia: 30.01.2023) (in Russian).] 4. Maheux-Lacroix S, Boutin A, Moore L et al. Hysterosalpingosonography for the diagnosis of tubal occlusion in subfertile women: a systematic review with meta-analysis. Hum Reprod 2014; 29 (5): 953–63. DOI: 10.1093/humrep/deu 02 5. Khan KN, Fujishita A, Mori T. Pathogenesis of human adenomyosis: current understanding and its association with infertility. J Clin Med 2022; 11 (14): 4057. 6. Munro MG. Classification and reporting systems for adenomyosis. J Min Invasive Gynecol 2020; 27 (2): 296–308. 7. Bulun SE et al. Adenomyosis pathogenesis: insights from next-generation sequencing. Hum Reprod Update 2021; 27 (6): 1086–97. 8. Emge LA. The elusive adenomyosis of the uterus: its historical past and its present state of recognition. Am J Obst Gynecol 1962; 83 (12): 1541–63. 9. Templeman C et al. Adenomyosis and endometriosis in the California Teachers Study. Fertil Steril 2008; 90 (2): 415–24. 10. Jean-Baptiste H et al. Characteristics associated with postoperative diagnosis of adenomyosis or combined adenomyosis with fibroids. Int J Gynecol Obstet 2013; 122 (2): 112–4. 11. Morassutto C et al. Incidence and estimated prevalence of endometriosis and adenomyosis in Northeast Italy: a data linkage study. PloS One 2016; 11 (4): e0154227. 12. Harada T et al. The impact of adenomyosis on women's fertility. Obstet Gynecol Survey 2016; 71 (9): 557. 13. Szubert M et al. Adenomyosis and infertility – review of medical and surgical approaches. Int J Environmental Res Public Health 2021; 18 (3): 1235. 14. Jungwirth A, Giwercman A, Tournaye N et al. Recommendations of the European Association of Urologists on Male infertility: 2012 update. Eur Urol 2012; 62 (2): 324–32. 15. Mavrelos D et al. The impact of adenomyosis on the outcome of IVF–embryo transfer. Reprod BioMed Online 2017; 35 (5): 549–54. 16. Committee of Practice of the American Society of Reproductive Medicine. Management of non-obstructive azoospermia: the conclusion of the committee. Fertil Infertil 2018; 110 (7): 1239–45. 17. Sharma S et al. Does presence of adenomyosis affect reproductive outcome in IVF cycles? A retrospective analysis of 973 patients. Reprod BioMed Online 2019; 38 (1): 13–21. 18. Puente JM et al. Adenomyosis in infertile women: prevalence and the role of 3D ultrasound as a marker of severity of the disease. Reprod Biol Endocrinol 2016; 14 (1): 1–9. 19. Günther V et al. Impact of Adenomyosis on Infertile Patients – Therapy Options and Reproductive Outcomes. Biomed 2022; 10 (12): 3245. 20. Bergeron C, Amant F, Ferenczy A. Pathology and physiopathology of adenomyosis. Best Practice Res Clin Obstet Gynaecol 2006; 20 (4): 511–21. 21. Leyendecker G, Wildt L, Mall G. The pathophysiology of endometriosis and adenomyosis: tissue injury and repair. Arch Gynecol Obstet 2009; 280: 529–38. 22. Sztachelska M et al. Functional Implications of Estrogen and Progesterone Receptors Expression in Adenomyosis, Potential Targets for Endocrinological Therapy. J Clin Med 2022; 11 (15): 4407. 23. Yen CF et al. Molecular characteristics of the endometrium in uterine adenomyosis and its biochemical microenvironment. Reprod Sci 2017; 24 (10): 1346–61. 24. Spencer TE et al. Comparative developmental biology of the mammalian uterus. Cur Topics Dev Biol 2005; 68: 85–122. 25. Khan KN, Fujishita A, Mori T. Pathogenesis of human adenomyosis: current understanding and its association with infertility. J Clin Med 2022; 11 (14): 4057. 26. Hoo PS, Norhaslinda AR, Reza JN. Rare case of leiomyoma and adenomyosis in Mayer-Rokitansky-Kuster-Hauser syndrome. Case Rep Obstet Gynecol 2016; 2016. 27. Schwab KE, Gargett CE. Co-expression of two perivascular cell markers isolates mesenchymal stem-like cells from human endometrium. Hum Reprod 2007; 22 (11): 2903–11. 28. Koike N et al. Pathogenesis and malignant transformation of adenomyosis. Oncol Rep 2013; 29 (3): 861–7. 29. Hufnagel D et al. The role of stem cells in the etiology and pathophysiology of endometriosis. Semin Reprod Med 2015; 33 (5): 333–40. 30. Khan KN, Fujishita A, Mori T. Pathogenesis of human adenomyosis: current understanding and its association with infertility. J Clin Med 2022; 11 (14): 4057. 31. Wilczyński JR et al. Endometriosis Stem Cells as a Possible Main Target for Carcinogenesis of Endometriosis-Associated Ovarian Cancer (EAOC). Cancers 2022; 15 (1): 111. 32. Vannuccini S et al. Pathogenesis of adenomyosis: an update on molecular mechanisms. Reprod Biomed Online 2017; 35 (5): 592–601. 33. Catalanotto C, Cogoni C, Zardo G. MicroRNA in control of gene expression: an overview of nuclear functions. Int J Mol Sci 2016; 17 (10): 1712. 34. Hirakawa T et al. miR-503, a microRNA epigenetically repressed in endometriosis, induces apoptosis and cell-cycle arrest and inhibits cell proliferation, angiogenesis, and contractility of human ovarian endometriotic stromal cells. Hum Reprod 2016; 31 (11): 2587–97. 35. Barrier BF et al. Adenomyosis in the baboon is associated with primary infertility. Fertil Steril 2004; 82: 1091–4. 36. Buggio L et al. Adenomyosis: fertility and obstetric outcome. A comprehensive literature review. Minerva Ginecol 2017; 70 (3): 295–302. 37. Maubon A et al. Uterine junctional zone at magnetic resonance imaging: a predictor of in vitro fertilization implantation failure. J Obstet Gynaecol Res 2010; 36 (3): 611–8. 38. Senturk LM, Imamoglu M. Adenomyosis: what is new? Women's Health 2015; 11 (5): 717–24. 39. Xiao Y et al. Expression of integrin β3 and osteopontin in the eutopic endometrium of adenomyosis during the implantation window. Eur J Obstet Gynecol Reprod Biol 2013; 170 (2): 419–22. 40. Zeng X et al. NR4A1 is involved in fibrogenesis in ovarian endometriosis. Cell Physiol Biochem 2018; 46 (3): 1078–90. 41. Yao MWM et al. Gene expression profiling reveals progesterone-mediated cell cycle and immunoregulatory roles of Hoxa-10 in the preimplantation uterus. Mol Endocrinol 2003; 17 (4): 610–27. 42. Surrey ES, Minjarez DA, Schoolcraft WB. The incidence of aberrant endometrial αvβ 3 vitronectin expression in a high risk infertility population: could prolonged GnRH agonist therapy play a role? J Assist Reprod Genetics 2007; 24: 553–6. 43. Garcıa P et al. Expression of αv, α4, α5 and β3 integrin subunits, fibronectin and vitronectin in goat peri-implantation. Animal Reprod Sci 2004; 80 (1–2): 91–100. 44. Carrarelli P et al. Expression of inflammatory and neurogenic mediators in adenomyosis: a pathogenetic role. Reprod Sci 2017; 24 (3): 369–75. 45. Benagiano G, Brosens I, Habiba M. Structural and molecular features of the endomyometrium in endometriosis and adenomyosis. Hum Reprod Update 2014; 20 (3): 386–402. 46. Оразов М.Р., Радзинский В.Е., Носенко Е.Н. и др. Иммуновоспалительные предикторы синдрома тазовой боли, связанного с аденомиозом. Гинекология и эндокринология. 2017; 33 (Прил. S1): 44–6. [Orazov M.R., Radzinskii V.E., Nosenko E.N. i dr. Immunovospalitel'nye prediktory sindroma tazovoi boli, sviazannogo s adenomiozom. Ginekologiia i endokrinologiia. 2017; 33 (Pril. S1): 44–6 (in Russian).] 47. Ota H et al. Involvement of catalase in the endometrium of patients with endometriosis and adenomyosis. Fertil Steril 2002; 78 (4): 804–9. 48. Nyachieo A, Siristatidis CS, Vaidakis D. Nonsteroidal anti‐inflammatory drugs for assisted reproductive technology. Cochrane Database Sys Rev 2019; 10. 49. Tamura H et al. The clinical outcome of Dienogest treatment followed by in vitro fertilization and embryo transfer in infertile women with endometriosis. J Ovarian Res 2019; 12: 1–9. 50. Hou X et al. The effect of adenomyosis on IVF after long or ultra-long GnRH agonist treatment. Reprod Biomed Online 2020; 41 (5): 845–53. 51. Younes G, Tulandi T. Effects of adenomyosis on in vitro fertilization treatment outcomes: a meta-analysis. Fertil Steril 2017; 108 (3): 483–90.e3. 52. Cozzolino M et al. The effect of uterine adenomyosis on IVF outcomes: a systematic review and meta-analysis. Reprod Sci 2022; р. 1–17. 53. Maia Jr H et al. Insertion of mirena after endometrial resection in patients with adenomyosis. J Am Assoc Gynecol Laparoscopists 2003; 10 (4): 512–6. 54. Saremi AT et al. Treatment of adenomyomectomy in women with severe uterine adenomyosis using a novel technique. Reprod Biomed Online 2014; 28 (6): 753–60. 55. Colombo N et al. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up. Int J Gynecol Cancer 2016; 26 (1). 56. Nirgianakis K et al. Fertility, pregnancy and neonatal outcomes of patients with adenomyosis: a systematic review and meta-analysis. Reprod Biomed Online 2021; 42 (1): 185–206. 57. De Bruijn AM et al. Uterine artery embolization for the treatment of adenomyosis: a systematic review and meta-analysis. J Vasc Int Radiol 2017; 28 (12): 1629–42.e1